Poster Title

MS-275 to modulate NK cell response against Osteosarcoma. Implication of the chemokines CXCL9/CXCL10

Authors

Uchechi Norah Asika, The University of Texas MD Anderson Cancer CenterFollow
Ariana Rupp Anjier, The University of Texas MD Anderson Cancer Center
Yuanzheng Yang, The University of Texas MD Anderson Cancer Center
Pradeep Shrestha, The University of Texas MD Anderson Cancer Center
Anchit Bhagat, The University of Texas MD Anderson Cancer Center
Nancy Gordon, The University of Texas MD Anderson Cancer Center

Files

Keywords

Histone Deacetylase inhibitor (HDAC), MS-275, Entinostat, osteosarcoma, chemokines

Program Affiliation

Summer Program in Cancer Research

Recommended Citation

Asika, Uchechi Norah; Rupp Anjier, Ariana; Yang, Yuanzheng; Shrestha, Pradeep; Bhagat, Anchit; and Gordon, Nancy, "MS-275 to modulate NK cell response against Osteosarcoma. Implication of the chemokines CXCL9/CXCL10" (2022). Summer Experience 2022. 43.
https://openworks.mdanderson.org/sumexp22/43